Medical economics

Groups make own drugs to fight high drug prices, shortages

Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages ...

Medical economics

Patients burdened by cost of diagnostic imaging interpretations

(HealthDay)—Secondary interpretations of diagnostic imaging examinations result in small but real patient financial burdens, according to a study published online July 19 in the Journal of the American College of Radiology.

page 12 from 40